Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.31.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.367EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.385EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.244EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.17.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.7.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.10.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.19.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.355EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.403EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.85EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.66 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.72 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.133 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.7 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.33.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.30 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.85 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used